SLC5A2 and diabetes mellitus: In a comprehensive omics analysis of a series of experimental studies, Billing et al. elegantly demonstrated that dapagliflozin reduced microbiome formation of uremic toxins such as p-cresol sulfate in rats, Sglt2 knockout mice, as well as in patients with diabetes or decompensated heart failure [23].